Novo Nordisk Sues Hims Over Copycat Wegovy
Novo Nordisk is suing telehealth company Hims & Hers, accusing it of illegally mass marketing cheaper, unapproved compounded versions of Wegovy.
More Videos
Robotaxis Vs. New York City: Can Self-Driving Cars Survive the Toughest Streets on Earth?
Waymo eyes NYC, the hardest city for robotaxis yet. Safety, laws, unions, and public trust collide as autonomous cars push toward America’s streets.
Watch Josh Luber Unbox the Future of Collectibles Live on the NYSE Floor
Josh Luber reveals the thrill of “blind boxification” and how chance-driven collectibles are reshaping markets in real time.
Seahawks vs. Patriots: The Biggest Bets You Need to Know
BetMGM CEO Adam Greenblatt shares the hottest bets, surprising trends, and how prediction markets are changing the game.
From Social Feeds to Super Bowl: The Rise of Creator-Led Ads
Zoe Soon of IAB explains how TikTok and Instagram stars are now the real MVPs of Super Bowl advertising campaigns.
Go Fund Yourself: High-End Assets to High-Impact Giving
Vaulté Management is redefining luxury investing through tokenized real-world assets. Plus, InstantNonprofit is modernizing how nonprofits raise money.
Who Really Controls TikTok Now? Inside the U.S. Spin-Off
As TikTok announces a major U.S. spin-off, Kerry Flynn, Media Reporter at Axios, breaks down the deal, the timing, and what it means for tech policy.
